Marc Bernard

2.6k citations

46 papers · 1.5k indexed · h-index 24

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 15
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 5
Microbiology 1

Co-authors: Laurence Amiot (11 shared papers)Thierry Lamy (11 shared papers)R Fauchet (9 shared papers)Bernard Drénou (10 shared papers)Yasmine Sebti (4 shared papers)Brigitte Birebent (4 shared papers)Olivier Fardel (6 shared papers)G. Sémana (4 shared papers)
Journals: Blood (6 papers)British Journal of Haematology (5 papers)Leukemia (2 papers)Haematologica (2 papers)Human Immunology (2 papers)
Partner nations: France India Morocco

In The Last Decade

Marc Bernard

45 papers receiving 1.5k citations

Peers

Countries citing papers authored by Marc Bernard

Since Specialization

Citations

This map shows the geographic impact of Marc Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Bernard more than expected).

Fields of papers citing papers by Marc Bernard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Bernard. The network helps show where Marc Bernard may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc Bernard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc Bernard Line = papers co-authored together Marc Bernard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction Blood ·Mehdi Alizadeh, Marc Bernard, Bruno Danic, Charly Dauriac, Brigitte Birebent, Christine Lapart, Thierry Lamy, Pierre‐Yves Le Prise, A Beauplet, Dominique Bories, G. Sémana, Erwann Quelvennec	2002	274
2	Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study Haematologica ·Mathilde Hunault, P. Chevallier, Martine Delain, C.-E. Bulabois, S. Bologna, Marc Bernard, Ingrid Lafon, Jérôme Cornillon, Abdallah Maakaroun, A. Tizon, Bruno Padrazzi, Norbert Ifrah, Yves Gruel, (unknown)	2008	111
3	Soluble HLA-G Molecules Are Increased during Acute Leukemia, Especially in Subtypes Affecting Monocytic and Lymphoid Lineages' Neoplasia ·Frédéric Gros, Yasmine Sebti, Sophie de Guiber, Bernard Branger, Marc Bernard, R Fauchet, Laurence Amiot	2006	74
4	Soluble HLA-G molecules are increased in lymphoproliferative disorders Human Immunology ·Yasmine Sebti, Gaëlle Le Friec, Céline Pangault, Frédéric Gros, Bernard Drénou, Valérie Guilloux, Marc Bernard, Thierry Lamy, R Fauchet, Laurence Amiot	2003	66
5	Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC) British Journal of Haematology ·Marie Robin, Reza Tabrizi, Mohamad Mohty, Sabine Fürst, Mauricette Michallet, Jacques‐Olivier Bay, Jean‐Yves Cahn, Eric De Coninck, Nathalie Dhédin, Marc Bernard, Bernard Rio, Agnès Buzyn, Anne Huynh, Karin Bilger, Pierre Bordigoni, Nathalie Contentin, Raphaël Porcher, Gèrard Socié, Nöel Milpied	2010	64
6	Inapparent Polycythemia Vera: An Unrecognized Diagnosis The American Journal of Medicine ·Thierry Lamy, Anne Devillers, Marc Bernard, Annick Moisan, I Grulois, Bernard Drénou, Laurence Amiot, R Fauchet, P. Y. Le Prise	1997	62
7	Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia Blood ·Éric Solary, Bernard Drénou, Lydia Campos, Patricia de Crémoux, Francine Mugneret, Philippe Moreau, Bruno Lioure, A. Falkenrodt, Brigitte Witz, Marc Bernard, Mathilde Hunault, Martine Delain, José Fernandes, Christiane Mounier, François Guilhot, Francine Garnache, Christian Berthou, Fawzi Kara-Slimane, Jean‐Luc Harousseau, (unknown)	2003	62
8	Expression of functional soluble human leucocyte antigen‐G molecules in lymphoproliferative disorders British Journal of Haematology ·Yasmine Sebti, Amélie Le Maux, Frédéric Gros, Sophie de Guibert, Céline Pangault, Nathalie Rouas‐Freiss, Marc Bernard, Laurence Amiot	2007	57
9	Visceral leishmaniasis in a dog: clinical, hematological and pathological observations. PubMed ·L. Tryphonas, Z. Zawidzka, Marc Bernard, Eugene Janzen	1977	56
10	The Clinical Spectrum of IgM-Related Amyloidosis Medicine ·Benjamin Terrier, Arnaud Jaccard, Jean‐Luc Harousseau, Richard Delarue, Olivier Tournilhac, Mathilde Hunault, M. Hamidou, Jacques Dantal, Marc Bernard, B. Grosbois, Pierre Morel, Valérie Coiteux, O. Gisserot, Philippe Rodon, A. Hot, Caroline Elie, Véronique Leblond, Jean‐Paul Fermand, Fádi Fakhouri	2008	54
11	Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. PubMed ·Thierry Lamy, Bernard Drénou, I Grulois, Olivier Fardel, Christian Jacquelinet, J Goasguen, Charles Dauriac, Laurence Amiot, Marc Bernard, R Fauchet	1995	53
12	HLA-G and lymphoproliferative disorders Seminars in Cancer Biology ·Laurence Amiot, Gaëlle Le Friec, Yasmine Sebti, Bernard Drénou, Céline Pangault, Valérie Guilloux, Xavier Leleu, Marc Bernard, Thierry Façon, R Fauchet	2003	48
13	High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival British Journal of Haematology ·Béatrice Laupèze, Laurence Amiot, Bernard Drénou, Marc Bernard, B. Branger, Jean Grosset, T. Lamy, R Fauchet, Olivier Fardel	2002	47
14	Human CD34-Positive Hematopoietic Stem Cells Constitute Targets for Carcinogenic Polycyclic Aromatic Hydrocarbons Journal of Pharmacology and Experimental Therapeutics ·Julien van Grevenynghe, Marc Bernard, Sophie Langouët, C. Le Berre, Thierry Fest, Olivier Fardel	2005	45
15	Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells Clinical & Experimental Immunology ·Amélie Le Maux, G. R. Noel, Brigitte Birebent, J-M. Grosset, Nicolas Vu, Sophie de Guibert, Marc Bernard, G. Sémana, Laurence Amiot	2008	36
16	Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo(a)pyrene Toxicology in Vitro ·Normand Podechard, Olivier Fardel, Michel Corolleur, Marc Bernard, Valérie Lecureur	2009	33
17	Prevalence of anal symptoms in general practice: a prospective study BMC Family Practice ·(unknown), Géraldine Tournu, (unknown), Laurent Abramowitz, Camille Couffignal, F. Juguet, A. Senéjoux, Stéphane Berger, Anne-Laure Wiart, Marc Bernard, Françoise Provost, Hélène Pillant-Le Moult, D. Bouchard, Jean‐Pierre Aubert	2017	28
18	Potassium antimonyl tartrate induces caspase‐ and reactive oxygen species‐dependent apoptosis in lymphoid tumoral cells British Journal of Haematology ·Valérie Lecureur, Aurélien Le Thiec, Alexandre Le Meur, Laurence Amiot, Bernard Drénou, Marc Bernard, Thierry Lamy, R Fauchet, Olivier Fardel	2002	28
19	Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30 ⁺ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program Haematologica ·Aurore Perrot, Hélène Monjanel, Réda Bouabdallah, Philippe Quittet, Clémentine Sarkozy, Marc Bernard, Aspasia Stamatoullas, Cécile Borel, Krimo Bouabdallah, Emmanuelle Nicolas‐Virelizier, Marion Fournier, Franck Morschhauser, Pauline Brice	2016	27
20	Major histocompatibility complex abnormalities in non‐Hodgkin lymphomas British Journal of Haematology ·Bernard Drénou, Gaëlle Le Friec, Marc Bernard, Céline Pangault, Jean‐Marc Grosset, Thierry Lamy, R Fauchet, Laurence Amiot	2002	26

About Marc Bernard

Marc Bernard is a scholar working on Hematology, Microbiology, Genetics, Immunology and Rheumatology, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Immune Cell Function and Interaction (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Reproductive System and Pregnancy (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Hematology (555 citations), Genetics (323 citations), Immunology (410 citations), Transplantation (41 citations) and Reproductive Medicine (96 citations). Marc Bernard has collaborated with scholars based in France, India and Morocco. Frequent co-authors include Laurence Amiot, Thierry Lamy, R Fauchet, Bernard Drénou, Yasmine Sebti, Brigitte Birebent, Olivier Fardel, G. Sémana, Frédéric Gros and A Beauplet. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Haematologica and Human Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact